Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
Search
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Open Innovation Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Fact & Figures Boehringer Ingelheim RCV
Facts and figures speak a clear language. Only economic success enables us to implement our corporate vision.
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Purchasing
Purchasing at Boehringer Ingelheim
Corporate Profile
Corporate Profile
Boehringer Ingelheim Austria - Value through Innovation
Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies with over 130 years of experience.
History (1990-2022): Value through Innovation
Boehringer Ingelheim's secret recipe in a constantly changing healthcare market: creating value through innovation.
Human Health Innovation
Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Animal Health Innovation
Animal Health Innovation
Science & Innovation
Innovation Wir verbessern die Gesundheit und die Lebensqualität von Patienten. Das ist seit 130 Jahren das zentrale Ziel des forschenden Pharmaunternehmens Boehringer Ingelheim.
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Our Countries
Our Countries
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Data Privacy-video surveillance at Boehringer Ingelheim
Data Protection Notice for video surveillance